摘要
目的:探讨优化新生脉散联合西药治疗慢性心力衰竭的效果。方法:选取2013年1月-2015年1月我院收治的80例气虚血瘀水饮证慢性心力衰竭患者,按照随机数字表法将患者分为对照组和观察组各40例,对照组予以规范西药治疗,观察组在对照组治疗基础上予以优化新生脉散方治疗。比较两组患者的心功能分级疗效、超声心动图指标、六分钟步行距离、生存质量评分。结果:观察组的心功能分级总有效率为87.50%,明显高于对照组的70.00%(P<0.05)。治疗前后,两组患者的每搏输出量、每分输出量、心脏指数等差异均无统计学意义(P>0.05);治疗前,观察组的射血分数与对照组的差异无统计学意义(P>0.05);治疗后,两组患者的射血分数均明显高于治疗前,且观察组明显高于对照组。结论:在慢性心力衰竭患者中应用优化新生脉散方联合西药治疗能有效提高疗效、射血分数。
Objective： To explore efcacy of Xin Shengmai San plus western medicine on chronic heart failure. Methods： 80 cases of CHF with the Qixu Xueyu Shuiyin syndrome were randomly divided into the control group and observation group, 40 cases in each. The control group was treated in western medicine; the observation group was given Xin Shengmai San more. NYHA, echocardiographic indexes, 6-minutes walk test and the quality of life scores were compared. Results： The total efciency was 87.50% in the observation group, signifcantly higher than 70.00% in the control group （P〈0.05）. The diferences of stroke volume, minute volume and cardiac index between before and after treatment in groups were not statistically signifcant （P〉0.05）. Before treatment, the ejection fraction in groups showed no statistically signifcant diference （P〉0.05）. After treatment, the ejection fraction in the observation group was signifcantly higher than that in the control group. Conclusion： Xin Shengmai San plus western medicine on chronic heart failure can efectively improve the curative efect and the ejection fraction.
出处
《中医临床研究》
2016年第28期20-22,共3页
Clinical Journal Of Chinese Medicine
